Navigation Links
Cellular Defects in Premature Aging Disease are Reversible

Cells affected by Hutchinson-Gilford Progeria Syndrome (HGPS) -- a disease associated with premature aging -- can be made healthy again, according to findings by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Using specially modified segments of DNA, NCI researchers Paola Scaffidi, PhD, and Tom Misteli, PhD, reversed the abnormalities seen in HGPS cells by correcting defects associated with the key protein, lamin A. By demonstrating that HGPS cellular characteristics are reversible, this study, appearing in Nature Medicine online on March 6, 2005, brings scientists one step closer to understanding this devastating childhood disease and might provide insights into the normal aging process.

HGPS is a rare inherited disease affecting about one in eight million children. While appearing normal at birth, infants with HGPS age rapidly after their first 18 months, and physical symptoms include stunted growth, loss of hair and body fat, joint stiffness, osteoporosis, and heart problems. The condition is fatal, with heart disease being the leading killer, and affected children usually die before they reach their late teens.

Less than two years ago, NIH-led researchers discovered that the genetic basis for HGPS is a single mutation in the gene encoding lamin A. Lamin A is a critical structural protein that acts as the scaffolding which holds a cell's nucleus together. Lamin A is defective in HGPS cells because the mutation creates an aberrant splice site in the lamin A gene; the aberrant splicing, or joining the separate parts of the gene together, results in synthesis of a truncated lamin protein. Without lamin A holding them together, the nuclei of progeria cells become wrinkled and misshapen. In addition, numerous other nuclear proteins show reduced expression.

"Our NCI team at the Center for Cancer Research in Bethesda set out to ask whether these cellular changes associated with progeria are perm anent or reversible," said Scaffidi. First, the investigators added DNA encoding normal lamin A into cells taken from patients affected with progeria, but observed that increased synthesis of normal lamin A did not correct any of the progeria-associated defects. In addition, they found that introduction of the mutant protein into healthy human cells was sufficient to produce the disease characteristics. "These results made it clear that in order to achieve a potential therapeutic effect, we needed to completely eliminate the mutant protein," said Scaffidi.

The NCI researchers designed a chemically stable DNA oligonucleotide ?a short DNA sequence that the cell wouldn't be able to degrade ?that would bind to the mutant splice site and prevent the splicing machinery from cutting in the wrong place. "You can think of it as a molecular Band-Aid®," said Misteli. The researchers inserted their oligonucleotides into the progeria cells and observed that after four days almost all the mutant lamin A transcripts had been eliminated and replaced with the properly spliced counterpart. The oligonucleotide was highly specific to the mutated region and did not cover-up other splicing locations. One week after correcting the splicing defect, the mutant lamin A protein had been eliminated and more than 90 percent of progeria cells were restored to normal; visually, the nuclei lost their wrinkles and lobes and returned to a natural ellipsoid shape, and the expression of other nuclear proteins was also restored to normal levels.

"It's amazing that we could take a cell that looked about ready to die, and a few days later it was healthy and ready to divide again," said Misteli.

Misteli noted that these results demonstrate a proof-of-principle that the cellular effects of progeria can be reversed, meaning his laboratory's method could be used some day in the future as a therapeutic strategy. The fact that a progeria reversal can be achieved in multiple cell types, and that the cells can return to normal, independent of cell division, bolsters this possibility. "Some tissues in our body do not divide," Misteli pointed out. "So demonstrating that we can rescue the normal phenotype without cell division means this procedure could be effective in all tissues." Misteli and his group will also look more closely at healthy cells to determine how similar progeria is to the normal aging process.

For more information about progeria, please visit the NHGRI Web site at



Related biology news :

1. Molecular Motors Cooperate In Moving Cellular Cargo, Study Shows
2. Cellular scale drug delivery from the inside out
3. Cellular antennae on algae give clues to how human cells receive signals
4. Cellular traffic backups implicated in skeletal malformations
5. Number Of Babies Born Prematurely Nears Historic Half Million Mark In U.S.
6. Premature births may be linked to seasonal levels of pesticides and nitrates in surface water
7. Research on Worms Yields Clues on Aging
8. Young Blood Revives Aging Muscles, Stanford Researchers Find
9. Gene Expression in the Aging Brain
10. Aging cells, aging body: Fresh evidence for a connection
11. Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
Post Your Comments:

(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
(Date:11/12/2015)... --  Growing need for low-cost, easy to use, ... the way for use of biochemical sensors for ... clinical, agricultural, environmental, food and defense applications. Presently, ... applications, however, their adoption is increasing in agricultural, ... on improving product quality and growing need to ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015  HUYA Bioscience International, the ... pharmaceutical innovations, today announced it has signed ... Fund (KDDF) to foster collaboration between KDDF and HUYA ... commercialization of healthcare products for the global market. ... important source of new innovative preclinical and clinical stage ...
(Date:11/30/2015)... Florida and MAGDEBURG, Germany , ... of NeuroRehabilitation (ECNR) in Vienna, Austria ... 3rd European Congress of NeuroRehabilitation (ECNR) in ... --> NovaVision, a wholly owned subsidiary of Vycor ... European version of its Internet-delivered NovaVision Therapy Suite at the ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 BrainStorm ... developer of adult stem cell technologies for neurodegenerative diseases, today ... been awarded an additional grant of approximately $735,000 from ... This grant, the second this year, brings the total awarded ... million (approximately NIS7 million).  ...
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased to ... presentations offered in symposia, oral sessions, workshops, awards, and posters. The core ... of applications such as, but not limited to, biotechnology, biomedical, drug discovery, environmental, ...
Breaking Biology Technology: